#als-treatment

[ follow ]
#drug-market-withdrawal
www.npr.org
4 months ago
Medicine

Lots of drug companies talk about putting patients first but this one actually did

Key Takeaway: Amylyx Pharmaceuticals voluntarily pulled their ALS drug from the market after a study revealed it wasn't effective, demonstrating commitment to integrity and ethics. [ more ]
Ars Technica
5 months ago
Medicine

$158,000 ALS drug pulled from market after failing in large clinical trial

The drug Relyvrio, approved for ALS treatment, did not show benefits in a clinical trial and is being pulled from the market.
The FDA approved Relyvrio despite shaky data, and the drug's failure highlights the need for more effective ALS treatments. [ more ]
www.npr.org
4 months ago
Medicine

Lots of drug companies talk about putting patients first but this one actually did

Key Takeaway: Amylyx Pharmaceuticals voluntarily pulled their ALS drug from the market after a study revealed it wasn't effective, demonstrating commitment to integrity and ethics. [ more ]
Ars Technica
5 months ago
Medicine

$158,000 ALS drug pulled from market after failing in large clinical trial

The drug Relyvrio, approved for ALS treatment, did not show benefits in a clinical trial and is being pulled from the market.
The FDA approved Relyvrio despite shaky data, and the drug's failure highlights the need for more effective ALS treatments. [ more ]
moredrug-market-withdrawal
www.nytimes.com
6 months ago
Medicine

A.L.S. Drug Relyvrio Fails Clinical Trial and May Be Withdrawn From the Market

FDA-approved ALS treatment Relyvrio failed a large clinical trial.
Results showed the treatment did not work better than a placebo. [ more ]
[ Load more ]